Increased NFAT and NFκB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of cystic fibrosis
Open Access
- 4 February 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (2) , e1012784
Abstract
Aspergillus fumigatus (Af) is a major mould pathogen found ubiquitously in the air. It commonly infects the airways of people with cystic fibrosis (CF) leading to Aspergillus bronchitis or allergic bronchopulmonary aspergillosis. Resident alveolar macrophages and recruited neutrophils are important first lines of defence for clearance of Af in the lung. However, their contribution to the inflammatory phenotype in CF during Af infection is not well understood. Here, utilising CFTR deficient mice we describe a hyperinflammatory phenotype in both acute and allergic murine models of pulmonary aspergillosis. We show that during aspergillosis, CFTR deficiency leads to increased alveolar macrophage death and persistent inflammation of the airways in CF, accompanied by impaired fungal control. Utilising CFTR deficient murine cells and primary human CF cells we show that at a cellular level there is increased activation of NFκB and NFAT in response to Af which, as in in vivo models, is associated with increased cell death and reduced fungal control. Taken together, these studies indicate that CFTR deficiency promotes increased activation of inflammatory pathways, the induction of macrophage cell death and reduced fungal control contributing to the hyper-inflammatory of pulmonary aspergillosis phenotypes in CF.Keywords
Funding Information
- Wellcome Trust (097377/z/11/z)
- Cystic Fibrosis Trust (SRC015)
- Wellcome Trust (219551/z/19/z)
- Medical Research Council (MR/V037315/1)
This publication has 83 references indexed in Scilit:
- Epithelial uptake leads to fungal killing in vivo and is aberrant in COPD-derived epithelial cellsiScience, 2024
- Prevalence of Aspergillus Sensitization and Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma: A Systematic Review of Global DataThe Journal of Allergy and Clinical Immunology: In Practice, 2023
- Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosisJournal of Controlled Release, 2022
- Macrophages from gut-corrected CF mice express human CFTR and lack a pro-inflammatory phenotypeJournal of Cystic Fibrosis, 2022
- The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre ApproachCurrent Fungal Infection Reports, 2017
- Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis AirwaysMycopathologia, 2017
- Novel immunologic classification of aspergillosis in adult cystic fibrosisJournal of Allergy and Clinical Immunology, 2013
- Oxidative stress and antioxidant therapy in cystic fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosisJournal of Cystic Fibrosis, 2010
- A mouse model for the cystic fibrosis delta F508 mutation.The EMBO Journal, 1995